Skip to main content
Annals of Surgery logoLink to Annals of Surgery
. 1976 Apr;183(4):358–364. doi: 10.1097/00000658-197604000-00005

In vitro penetration of topical antiseptics through eschar of burn patients.

M M Stefanides Sr, C E Copeland, S D Kominos, R B Yee
PMCID: PMC1344204  PMID: 1267492

Abstract

The ability of topical antiseptics to penetrate eschar of burn patients was determined by the agar diffusion technique. Gentamicin sulfate, mafenide acetate, nitrofurazone, povidone-iodine, silver nitrate, and silver sulfadiazine were tested against clinical isolates of Candida albicans, Staphylococcus, Streptococcus, and gram-negative bacilli including Pseudomonas aeruginosa. In practically all instances, the diameters of the zones of inhibition observed using eschar were comparable to those obtained with filter-paper discs. This finding showed that the antimicrobial agents could penetrate eschar and retain their effectiveness after penetration.

Full text

PDF
358

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BAZAN A., CHAVEZ P. M., GURMENDI G., MARKLEY K. Fatal Pseudomonas septicemias in burned patients. Ann Surg. 1957 Feb;145(2):175–181. doi: 10.1097/00000658-195702000-00005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brentano L., Gravens D. L., Moyer C. A., Monafo W. W., Jr Bacteriology of large human burns treated with silver nitrate. Arch Surg. 1966 Sep;93(3):456–466. doi: 10.1001/archsurg.1966.01330030086019. [DOI] [PubMed] [Google Scholar]
  3. Dressler D. P., Skornik W. A. Silver sulfadiazine and Sulfamylon cream in the burned rat model: a comparative evaluation. Surgery. 1970 Apr;67(4):644–649. [PubMed] [Google Scholar]
  4. Fox C. L., Jr, Rappole B. W., Stanford W. Control of pseudomonas infection in burns by silver sulfadiazine. Surg Gynecol Obstet. 1969 May;128(5):1021–1026. [PubMed] [Google Scholar]
  5. Fox C. L., Jr, Sampath A. C., Stanford J. W. Virulence of Pseudomonas infection in burned rats and mice. Comparative efficacy of silver sulfadiazine and mafenide. Arch Surg. 1970 Oct;101(4):508–512. doi: 10.1001/archsurg.1970.01340280060015. [DOI] [PubMed] [Google Scholar]
  6. Krizek T. J., Cossman D. V. Experimental burn wound sepsis: variations in response to topical agents. J Trauma. 1972 Jul;12(7):553–562. [PubMed] [Google Scholar]
  7. Moncrief J. A. Burns. N Engl J Med. 1973 Mar 1;288(9):444–454. doi: 10.1056/NEJM197303012880905. [DOI] [PubMed] [Google Scholar]
  8. Moncrief J. A. The status of topical antibacterial therapy in the treatment of burns. Surgery. 1968 May;63(5):862–867. [PubMed] [Google Scholar]
  9. Moncrief J. A. Topical therapy of the burn wound: present status. Clin Pharmacol Ther. 1969 Jul-Aug;10(4):439–448. doi: 10.1002/cpt1969104439. [DOI] [PubMed] [Google Scholar]
  10. Stanford W., Rappole B. W., Fox C. L., Jr Clinical experience with silver sulfadiazine, a new topical agent for control of pseudomonas infections in burns. J Trauma. 1969 May;9(5):377–388. doi: 10.1097/00005373-196905000-00002. [DOI] [PubMed] [Google Scholar]
  11. Stone H. H., Kolb L. D. The evolution and spread of gentamicin-resistant Pseudomonads. J Trauma. 1971 Jul;11(7):586–589. doi: 10.1097/00005373-197107000-00009. [DOI] [PubMed] [Google Scholar]

Articles from Annals of Surgery are provided here courtesy of Lippincott, Williams, and Wilkins

RESOURCES